Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03170440
Other study ID # IRB201700541
Secondary ID i01 rx003140-01a
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date November 30, 2024

Study information

Verified date November 2023
Source University of Florida
Contact De Miller-Sellers, DPT
Phone 352-317-1611
Email dolores.miller-sellers@va.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, our objective is to determine the effect of two different nerve stimulation types in changing sleep architecture.


Description:

Persons suffering from PTSD or mild TBI may suffer from sleep deprivation. The purpose of this study is to explore options to improve sleep quality.


Recruitment information / eligibility

Status Recruiting
Enrollment 221
Est. completion date November 30, 2024
Est. primary completion date October 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - veterans with history of PTSD with and without history of mild TBI Exclusion Criteria with: - history of severe psychiatric illness unrelated to PTSD or TBI - other medical conditions of severity that may impair cognition - current illicit or prescription drug abuse - breathing disorder requiring constant use of oxygen

Study Design


Intervention

Other:
Transcutaneous nerve stimulation location 1
Non-invasive stimulation by transcutaneous electrical nerve stimulation device in test location
Transcutaneous nerve stimulation location 2
Stimulation will be performed using electrodes placed in alternate location.

Locations

Country Name City State
United States North Florida/South Georgia Veterans Health System Gainesville Florida
United States University of Florida Gainesville Florida

Sponsors (3)

Lead Sponsor Collaborator
University of Florida North Florida/South Georgia Veterans Health System, US Department of Veterans Affairs

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physiological sleep architectural quality Polysomnography up to 8 hours
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1